What is Overjet?
Overjet is the global leader in dental artificial intelligence, providing sophisticated software solutions that empower dental practices and insurance companies to improve patient outcomes. Founded by experts from the Massachusetts Institute of Technology and Harvard School of Dental Medicine, the company distinguishes itself through its deep integration of clinical expertise and advanced AI technology. Overjet achieved a significant industry milestone in 2018 by securing FDA clearance for its Dental Assist product, marking it as the first dental AI company to reach such a regulatory benchmark. The firm's platform is designed to enhance diagnostic accuracy, streamline administrative processes, and foster transparency in dental care, effectively bridging the gap between clinical diagnostics and insurance claims processing.
How much funding has Overjet raised?
Overjet has raised a total of $130.3M across 4 funding rounds:
Angel/Seed
$7.8M
Series A
$27M
Series B
$42.5M
Series C
$53M
Angel/Seed (2020): $7.9M with participation from E14 Fund and Crosslink Capital
Series A (2021): $27M led by E14 Fund, General Catalyst, Insight Partners, and Crosslink Capital
Series B (2021): $42.5M supported by E14 Fund, General Catalyst, Crosslink Capital, and Insight Partners
Series C (2024): $53M featuring Insight Partners, E14 Fund, March Capital, General Catalyst, and Crosslink Capital
Key Investors in Overjet
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth technology and software companies, providing them with the operational support needed to scale effectively.
General Catalyst
General Catalyst is a venture capital firm that partners with founders to build enduring, transformational businesses across various sectors, including healthcare and enterprise software.
March Capital
March Capital is a growth-stage venture firm that specializes in investing in enterprise technology companies with established product-market fit, aiming to scale them into mission-critical global platforms.
What's next for Overjet?
With this latest infusion of capital, Overjet is well-positioned to accelerate its product roadmap and expand its market footprint. The company is expected to focus on deepening its enterprise software capabilities, further integrating its AI-driven insights into the workflows of large-scale dental service organizations and insurance carriers. As the demand for data-backed clinical decision support grows, Overjet's strategic focus will likely center on scaling its operations, enhancing its proprietary algorithms, and strengthening its position as the definitive standard for AI in dentistry. The continued support from its investor base provides the necessary resources to navigate the complexities of the healthcare technology landscape while maintaining its competitive edge in clinical diagnostics.
See full Overjet company page
